SONIA NIMTZ: Open Payments
NPI 1346883246 · GALVESTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$310 in 9 payments from 7 companies in 2025. Trend: 2023 $82 · 2024 $555 · 2025 $310
Food & beverage: $310
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 1 | $132 |
| Novartis Pharmaceuticals Corporation | 2 | $53 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $34 |
| Apellis Pharmaceuticals, Inc. | 1 | $29 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $26 |
| Novo Nordisk Inc | 1 | $21 |
| Lilly USA, LLC | 1 | $15 |
Products named: LEQVIO, JARDIANCE, Empaveli, Kerendia, Rivfloza, MOUNJARO.
Industry payments across TX — which companies pay providers there.
